Workshop Day | Tuesday 25th March, 2025 9:00 am Light Breakfast & Check-In 10:00 am Workshop A: Implementing AI & In Silico Technologies to De-Risk the Discovery of Induced Proximity Therapeutics & Accelerate Their Translation Andrew Potterton Chief Technology Officer, Ternary Therapeutics Alexandros Patsilinakos Head of Medicinal Chemistry, Sibylla Biotech 12:00 pm Lunch Break & Networking 1:00 pm Workshop B: Enhancing Oral Bioavailability of Bivalent Degraders to Improve Patient Exposure & Maximise Therapeutic Efficacy Zoran Rankovic Director, Center for Protein Degradation, Institute of Cancer Research Andy Pike Project leader, DMPK, Oncology R&D, AstraZeneca Koichi Ito Senior Director, Biology, Prelude Therapeutics 3:00 pm Afternoon Break & Networking 3:30 pm Workshop C: From Hit to Lead – Navigating Key Checkpoints for Go/No-Go Decisions on Turning Your Initial Hits into Functional Induced PROTACs Andrea Unzue Lopez Head TPD Chemistry, Merck Group Iacovos Michaelides Associate Principal Scientist, AstraZeneca 5:30 pm End of Pre-Conference Workshop Day For full session information, download the brochure DOWNLOAD NOW SPEAKER FACULTY CONFERENCE DAY ONE
